ARTV (Artiva Biotherapeutics, Inc.) Bozor kapitallashuvining balans qiymatiga nisbati
Artiva Biotherapeutics, Inc. (ARTV) ulkan ilmiy-tadqiqot va ishlanmalar xarajatlari va FDAning qattiq nazoratiga duch kelmoqda, bu esa yangi o'yinchilar uchun kirishga to'sqinlik qiladigan to'siqlarni yaratadi. Ularning NK-terapiyasida toksiklikning yo'qligi narxlash kuchini o'rnatish uchun yo'l ochadi, garchi aktivlarni baholash hozirda 0.58 darajasida bo'lsa va grantlarga bog'liq bo'lib qolmoqda. Ushbu narx jadvali ushbu biotexnologik startapning baholash dinamikasini ko'rsatadi.
%20Kapitallashuvning%20sof%20aktivlarga%20nisbati&width=1200&height=400&colorIndex=0&v=mvx9zauv.4e-7b561vk&start=20220704&end=20261101&filename=GURU_Markets_-_ARTV_-_Artiva-Biotherapeutics-Inc._-_Market-Cap-to-Net-Assets-Ratio "Artiva Biotherapeutics, Inc. (ARTV) Bozor kapitallashuvining balans qiymatiga nisbati: 20.07.2024 - 01.11.2026 davri uchun | 👁️GURU.Markets👁️")
Artiva Biotherapeutics, Inc. (ARTV) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti
- aksiya narxi va baholash bo'yicha konsensus prognoz:
- biznesning bozor baholash ko'rsatkichlari:
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
- qarzdorlik va likvidlik to'g'risida ma'lumotlar:
Umumiy qarzning kapitalga nisbati Artiva Biotherapeutics, Inc.|ARTV - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati artivabio.com|ARTV - Kompaniyaning umumiy yig'indi qarzi|Qarzning balans kapitallashuviga nisbati Artiva|ARTV - Kompaniyaning uzoq muddatli kredit va qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Artiva Biotherapeutics|Tezkor likvidlik koeffitsiyenti artivabio.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning har tomonlama tahlili:Artiva Biotherapeutics, Inc.
Investorlar ushbu metrikadan aktivlarning haddan tashqari qimmat baholanganini yoki biznesning yashirin zaifliklarini aniqlash uchun foydalanadilar. Ushbu metrika kompaniyaning joriy bozor qiymatini balans hisobotidagi sof aktivlari bilan solishtiradi. Kompaniyaga tegishli P/BV koeffitsiyenti dinamikasi kapital baholashidagi statistik chetlanishlarni kuzatish imkonini beradi. Artiva Biotherapeutics, Inc. (ARTV) uchun bunday baholash intellektual mulk qiymatiga tayanadi. AQSh va Janubiy Koreya ittifoqi doirasidagi patent himoyasi aktivlar qiymatining pasayishi xavfini minimallashtiradi.
Artiva Biotherapeutics, Inc. kimlar bilan raqobatlashadi
ONC (BeiGene Ltd) - Kapitallashuvning sof aktivlarga nisbati|HALO (halozyme.com) - Bozor qiymatining balans qiymatiga nisbati|RVMD (Revolution Medicines, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Ascentage Pharma Group International (AAPG)|Bozor kapitallashuvining balans qiymatiga nisbati CGON|Bozor kapitallashuvining balans qiymatiga nisbati UroGen Pharma Corp (URGN)|Bozor qiymatining balans qiymatiga nisbati Bicara Therapeutics Inc. BCAX|PSNL: Kapitallashuvning balans qiymatiga nisbati|Erasca - Bozor kapitallashuvining balans qiymatiga nisbati|Delcath Systems Inc (DCTH) - Kapitallashuvning sof aktivlarga nisbati|YMAB: Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Aura Corp (AURA)|Bozor qiymatining balans qiymatiga nisbati Candel Therapeutics Inc.|ARAY: Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati SLS (SELLAS Life Sciences)|ACTU (Actuate Therapeutics Inc.) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati CTOR (Citius Oncology, Inc)|HURA - Kapitallashuvning sof aktivlarga nisbati|TARA: Kapitallashuvning sof aktivlarga nisbati|FATE - Bozor kapitallashuvining balans qiymatiga nisbati|aadibio.com (WHWK) - Bozor qiymatining balans qiymatiga nisbati|TScan Therapeutics, Inc. - Balans qiymatiga nisbatan bozor qiymati|CSBR (Champions Oncology Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti XBiotech USA XBIT|Bozor kapitallashuvining balans qiymatiga nisbati CVM|Bozor kapitallashuvining balans qiymatiga nisbati ostherapies.com (OSTX)|Bozor qiymatining balans qiymatiga nisbati Radiopharm Theranostics RADX|Balans qiymatiga nisbatan bozor qiymati ANL|VERU: Kapitallashuvning sof aktivlarga nisbati|Tempest Therapeutics Corp - Bozor kapitallashuvining balans qiymatiga multiplikatori|XLO: Bozor kapitallashuvining balans qiymatiga nisbati|RENB - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati MURA|Bozor qiymatining balans qiymatiga nisbati KAPA|Bozor kapitallashuvining balans qiymatiga nisbati OKUR|Bozor kapitallashuvining balans qiymatiga nisbati w2.cytomed.sg (GDTC)|Curis - Kapitallashuvning sof aktivlarga nisbati|Balans qiymatiga nisbatan bozor qiymati APLM|Tharimmune - Bozor kapitallashuvining balans qiymatiga nisbati|ADVB: Bozor qiymatining balans qiymatiga nisbati|GNPX: Bozor kapitallashuvining balans qiymatiga nisbati|CLDI - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Sunshine Biopharma|Bozor qiymatining balans qiymatiga koeffitsiyenti Xenetic Bio XBIO|Kapitallashuvning sof aktivlarga nisbati SLRX (Salarius Pharmaceuticals, Inc.)|Bozor kapitallashuvining balans qiymatiga multiplikatori PPBT|Bozor kapitallashuvining balans qiymatiga nisbati AONC (American Oncology Network, Inc.)|Balans qiymatiga nisbatan bozor qiymati BGNE|Checkpoint Therapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Elevation Oncology Inc.|icadmed.com (ICAD) - Bozor qiymatining balans qiymatiga nisbati|Ikena Oncology - Balans qiymatiga nisbatan bozor qiymati|NTBL (Notable Labs Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Viracta|Bozor qiymatining balans qiymatiga nisbati MorphoSys AG (MOR)|NAYA: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati AAPGV (Ascentage Pharma)